Physician

Qin Zen, M.D., PHD

According to 2025 Medicare claims, Qin Zen, M.D., PHD (NPI: 1528283983) practices hematology/oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12206-5013.

Zen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,015 traditional Medicare patients, billed 165,327 HCPCS/CPT codes, and received $2,419,290 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,795 prescription claims across 285 beneficiaries totaling $7,165,150 in drug costs, led by Pomalyst (Pomalidomide). 2021 DME data shows 12 claims. Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,369,254 to $2,419,290. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,063,356 to $7,165,150. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,634 to $0.